Evidence map›Paper›PMID 36770881›Full record

ArticleMolecules (Basel, Switzerland)2023

Biosynthesized Silver Nanoparticles Using

Tipaporn Kumkoon, Monrudee Srisaisap, Panadda Boonserm

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. AqueousNanomaterials (Basel, Switzerland) · 2025
    Article
  7. Nanomaterials (Basel, Switzerland) · 2025
    Review
  8. Biogenic synthesis of silver nanoparticles usingBiotechnology notes (Amsterdam, Netherlands) · 2025
    Article
  9. Evaluating the pharmacological activities ofFood science & nutrition · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. MulberryGenes · 2023
    Article
  19. Green Synthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tipaporn KumkoonInstitute of Molecular Biosciences, Mahidol University, Nakhon Pathom 73170, Thailand.ORCID 0000-0002-1338-4395
Monrudee SrisaisapInstitute of Molecular Biosciences, Mahidol University, Nakhon Pathom 73170, Thailand.
Panadda BoonsermInstitute of Molecular Biosciences, Mahidol University, Nakhon Pathom 73170, Thailand.ORCID 0000-0002-2057-3944

Funding

Mahidol University Mahidol University (Basic Research Fund: fiscal year 2022)the National Research Council of Thailand (NRCT) and Mahidol University NRCT5-RSA63015-06
6 · The paper itself

Abstract

In this study, we report the green synthesis of silver nanoparticles (AgNPs) from

Indexed as

Antineoplastic AgentsMetal NanoparticlesAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsMorusPlant ExtractsSilverAnti-Bacterial AgentsAntineoplastic AgentsPlant ExtractsSilverantibacterial activityanticancer activityMorus alba extractsilver nanoparticles

Identifiers

PMID36770881
PMCPMC9920803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.